Cleared Traditional

K761305 - CENTRIA T3 RIA

K761305 is an FDA 510(k) clearance for CENTRIA T3 RIA, manufactured by Union Carbide Corp.. The device is a Class 2 Immunology device with product code CDP cleared through the Traditional 510(k) pathway after a 8-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1976
Decision
8d
Days
Class 2
Risk

K761305 is an FDA 510(k) clearance for the CENTRIA T3 RIA. Classified as Radioimmunoassay, Total Triiodothyronine (product code CDP), Class II - Special Controls.

Submitted by Union Carbide Corp. (Mchenry, US). The FDA issued a Cleared decision on December 30, 1976 after a review of 8 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1710 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K761305

510(k) Number K761305 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 22, 1976
Decision Date December 30, 1976
Days to Decision 8 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
97d faster than avg
Panel avg: 105d · This submission: 8d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CDP Device Classification - Class 2, Special Controls

Product Code CDP Radioimmunoassay, Total Triiodothyronine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1710
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CDP Radioimmunoassay, Total Triiodothyronine

All 143
Devices cleared under the same product code (CDP) and FDA review panel - the closest regulatory comparables to K761305.
RADIOIMMUNOASSAY, QUANTITIPE 125-I-T3
K770520 · Kallestad Laboratories, Inc. · Jun 1977
T-3 RIA REAGENT SET
K770677 · G.D. Searle and Co. · May 1977
T3 RIA (PEG) DIAGNOSTIC KIT
K770201 · Abbott Laboratories · Apr 1977
TEST, RIA, TRIODOTHYRONINE
K760057 · Smithkline Diagnostics, Inc. · Sep 1976
REAGENT, RIA TRIIODOTHYRONINE T3 (#200)
K760078 · Oxford Laboratories, Inc. · Jul 1976